FDA Inspection 1016285 — Maxim Biomedical Inc.
The FDA completed an inspection of Maxim Biomedical Inc. on May 18, 2017 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 18, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville, MD (United States)